1mg, best e pharmacy in India
MRP: Rs. 900 for 1 vial(s) (1 ML injection each)
Unfortunately, we don't have any more items in stock
Report Error

Composition for FRAXODI

Nadroparin(11.4 k)

food interaction for FRAXODI

alcohol interaction for FRAXODI

pregnancy interaction for FRAXODI

lactation interaction for FRAXODI

It can be taken with or without food, but it is better to take it at a fixed time.
Avoid it with valerian, kava kava and gotu kola.
Interaction with alcohol is unknown. Please consult your doctor.
It is probably safe to use during pregnancy.
Animal studies have shown no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.


Nadroparin(11.4 k)


Fraxodi 11.4k injection is used to prevent and treat deep vein thrombosis (a condition in which harmful blood clots form in the blood vessels of the legs, which can travel and become lodged in the blood vessels of the lungs, causing pulmonary embolism). Fraxodi 11.4k injection is also is used to treat unstable angina or certain types of heart attacks and to prevent blood clots from forming during hemodialysis.

How it works

Fraxodi 11.4k injection belongs to a group of medicines called as low molecular weight heparins (LMWHs).It works by halting the coagulation pathway of thrombin and fibrin clotting cascade, thereby preventing clot formation.

Common side effects

Injection site hematoma


No substitutes found

Top General Physicians

  • Dr. Balbir Singh
    MBBS, MD, DM, Fellowship, Fellowship
  • Dr. Hemant Gandhi
    MBBS, MD, DM
  • Dr. (Col.) Balbir Kalra
    MBBS, MD, DM
  • Dr. R. R. Kasliwal
    MBBS, MD, DM, Fellowship
  • Dr. Manjinder Sandhu
    MBBS, MD, DNB, DM, Fellowship, Fellowship

Expert advice for FRAXODI

  • Inform your doctor if you have liver disease, kidney disease or gastrointestinal ulceration.
  • You may need to regularly check and monitor for anti-factor Xa concentration, plasma and hemoglobin concentration and International Normalized Ratio (INR) during treatment with Nadroparin.
  • Your platelet counts should be determined prior to the commencement of therapy and twice a week for the duration of Nadroparin therapy.
  • Discontinue Nadroparin and seek immediate medical attention if you suffer from thrombocytopenia (deficiency of platelets in the blood).
  • Nadroparin may interfere with certain laboratory tests like liver function tests.
  • Inform your doctor if you are taking any medications such as aspirin or other drugs to reduce blood clotting such as warfarin.
  • Tell your doctor if you are pregnant, planning to become pregnant or are breastfeeding.


Content on this page was last updated on 17 January, 2015, by Dr. Varun Gupta (MD Pharmacology)